Treatment Plan for a Client Who Wants Only Detox

Plan from risk, not from the program's template. The dominant clinical fact is two overdoses in 12 months - the highest-probability cause of death here is a post-detox overdose, because tolerance drops during withdrawal. A plan that ignores this to enforce a 28-day norm is clinically negligent.

Plan elements:

• Medication for opioid use disorder (MOUD) discussion - buprenorphine or methadone - offered as the evidence-based lever against overdose. Frame it as not "more groups" and not "substituting one drug for another," which addresses his stated objection.
• Naloxone kit and overdose education for him and, with consent, his daughter - directly responsive to the two prior events.
• Detox as the entry point, not the endpoint. Write a plan with measurable, time-bound objectives he will accept: e.g., attend one MOUD induction appointment within 7 days; obtain naloxone before discharge; one follow-up contact within 48 hours of discharge.
• Address the social determinants he actually named: housing and transportation referrals, Medicaid-covered primary care.
• Document his refusal of residential, the risks explained, and his response - informed refusal, not noncompliance.

The plan is his goals plus the counselor's safety obligations, not the program's default package.

Educate, explore, and preserve the door - do not argue to win.

Steps:

1. Correct the misconception briefly and concretely: MOUD is a maintenance medication with a ceiling effect for buprenorphine, taken on a schedule, and it cuts overdose mortality substantially. Avoid a lecture; one or two sentences.
2. Ask what he's afraid of. "Trading one addiction" often masks fears about dependence, stigma, or being "hooked again." Address the actual fear.
3. Offer a low-commitment trial framing - e.g., start at discharge, reassess in two weeks - rather than a lifetime commitment.
4. If he still declines: accept it, document the education given and his refusal, and put overdose-prevention measures in place regardless (naloxone, safety plan, follow-up).
5. Revisit at each contact. Readiness shifts, especially after detox when withdrawal distress eases.

Key judgement: refusal of MOUD is not refusal of care. The counselor does not discharge him for declining a medication, and does not record him as "unmotivated."

Child safety is a planning element, not an aside.

• Assess the actual risk context: Is she present during use? Is there naloxone in the home and does an age-appropriate person know how to use it? Is there a safe adult she can reach? A 17-year-old is old enough to be given overdose-recognition and naloxone training with her consent and her father's - this is protective, not parentifying.
• Clarify her role with the father. She should not be positioned as his monitor or caretaker; that is a boundary issue and a treatment target.
• Mandatory reporting analysis: whether the situation meets the state's threshold for a child-welfare report depends on specific facts (supervision, exposure, imminent risk). Consult supervision and follow statute; document the decision and rationale either way.
• Include a family/support component in the plan if he consents - education for the daughter about overdose and about not being responsible for his recovery.

Document these decisions explicitly. A plan that lists only his individual goals and ignores a minor in the home is incomplete.